<DOC>
	<DOCNO>NCT01662492</DOCNO>
	<brief_summary>To evaluate efficacy safety Botulinum Toxin Type A versus placebo ( normal saline ) headache prophylaxis adolescent ( child 12 17 ) chronic migraine .</brief_summary>
	<brief_title>A Study Using Botulinum Toxin Type A Headache Prophylaxis Adolescents With Chronic Migraine</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Medical history chronic migraine least 6 month 15 headache day 4 week period Previous use botulinum toxin serotype reason Diagnosis Myasthenia gravis , EatonLambert Syndrome , Amyotrophic Lateral Sclerosis Treatment headache use acupuncture , transcutaneous electrical stimulation ( TENS ) , cranial traction , dental splint , injection anesthetics/steroids within 4 week prior week 4 screen visit Use headache prophylaxis medication within 4 week prior week 4 screening visit</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>